|Day Low/High||135.43 / 139.22|
|52 Wk Low/High||125.84 / 197.00|
DUBLIN, May 24, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY.
DUBLIN, May 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Commercial Officer William Meury will participate in a fireside chat at the Jefferies 2019 Healthcare Conference in New York, NY.
-- Five PLEDGE studies now active and enrolling patients to evaluate the safety and efficacy of relamorelin (investigational drug) in people with diabetic gastroparesis --
"With the evolving market conditions, we mutually agreed that the future of the variable annuity business in Japan is best served as a wholly-owned part of our longstanding partner Sony Life", said Alex Wynaendts, CEO of Aegon.
Jim Cramer says Thursday's market action showed us a rally based on good old-fashioned earnings.
These kinds of stocks are what goes up when there's so little left that hasn't moved that can still be worth buying.
DUBLIN, May 16, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the Bernstein 35 th Annual Strategic Decisions Conference in New York, NY.
Abstracts will showcase research on VRAYLAR, including a focus on an investigational use for the treatment of bipolar depression
PatientFi, LLC, a leading financial technology company that partners with medical practices to offer patients accessible financing plans for elective procedures, is pleased to announce its partnership with Allergan plc on a year-long market research study...
Novartis gets a potentially blockbuster eye drug and Takeda gets to unload some debt and employees it took on when it purchased Shire.
DUBLIN, May 9, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Chief Financial Officer Matthew Walsh will participate in a fireside chat at the Bank of America Merrill Lynch 2019 Health Care Conference in Las Vegas, Nevada.
Stocks end down sharply as markets react to latest twists in trade spat between the U.S. and China.
Regeneron stock is under pressure after missing on earnings and revenue expectations. Are new lows on tap?
Allergan posted stronger-than-expected first quarter earnings Tuesday, and boosted its full-year profit guidance, as Botox sales continue to drive top-line growth for the Dublin-based pharmaceutical group.
Shares of the maker of Botox are struggling despite its latest results exceeding expectations.
Global stocks were mixed higher Tuesday, while U.S. equity futures drifted modestly into the red, as investors kept risk appetite in check ahead of a key series of trade talks between Washington and Beijing later this week that could define or collapse an elusive pact between the world's two largest economies.
U.S. stock futures slump as investors focus on trade talks later this week between Washington and Beijing; Lyft will issue its first earnings report as a public company on Tuesday; Anadarko says it favors Occidental's takeover bid over Chevron's offer.
-- Q1 2019 GAAP Net Revenues of $3.60 Billion --
Aegon today announces that it is exercising its right to redeem the USD 500 million perpetual capital securities with a coupon of 6.
Six-Year, Multi-Center, Pivotal Clinical Trial Data of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg Presented at 2019 ACOG Meeting
Jim Cramer says the economy is just right for stocks, but he's still worried about IPO froth. Here's your game plan for next week.
- Dividend to be Paid on June 14, 2019 -
-New data will provide insights on treatment duration and biodegradation of the experimental implant in patients with open-angle glaucoma or ocular hypertension-
- Allergan MIND™, Allergan's migraine franchise, leads meeting with the most migraine presentations: 24 abstracts highlighting BOTOX® (onabotulinumtoxinA) for Chronic Migraine, ubrogepant and atogepant -
Jim Cramer says it's not 1987 or 1999, and there's no reason to dump stocks right now, but he does advocate discipline and caution.
Jim Cramer weighs in on Kohl's, Exxon Mobil, Delta Air Lines, Allergan, Arrowhead Research, Wayfair, Varonis Systems and more.
-- Shareholders Approved All Allergan Proposals and Voted AGAINST Shareholder Proposal Calling for Immediate Separation of Chairman and CEO Role --
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.